RxLibra

Search Generic Medicine

Medicine Index

Search by generic name

Generic Dabrafenib

Dabrafenib is a selective inhibitor of mutated forms of BRAF kinase and is used alone or in combination with trametinib  to treat certain types of cancer in people who have a “BRAF” gene mutation. dabrafenib is for use in treating:

  • for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations 
  • for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations and involvement of lymph node(s), following complete resection
  • for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation 
  • for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options

Limitations of Use: TAFINLAR is not indicated for the treatment of patients with wild-type BRAF melanoma, NSCLC, or ATC.

Dabrafenib sold as brand names  Tafinlar、Rafinlar among others.It has a generic form of several brands include:


PHODABRA Dabrafenib

Brand Name : PHODABRA
Composition : Dabrafenib 75mg
Indication: Antineoplastic-Multikinase inhibitors
Form : Capsule (Oral administration)
Packing : 120 Capsules in 1 box
Manufactured By:PHARMA 2 VIENTIANE [Laos]
Storage:Store at room temperature (2-8°C)

Dabrafedx Dabrafenib

Brand Name : Dabrafedx
Composition : Dabrafenib 75mg
Indication: Antineoplastic-Multikinase inhibitors
Form : Capsule (Oral administration)
Packing : 120 Capsules in 1 box
Manufactured By:DAXIONG [Laos]
Storage:Store at room temperature (2-8°C)

Tags:  ,

You must be logged in to post a comment.